CELEX: 62013TA0173
Language: en
Date: 2014-12-12 00:00:00
Title: Case T-173/13: Judgment of the General Court of 12 December 2014  — Selo Medical v OHIM — biosyn Arzneimittel (SELOGYN) (Community trade mark — Opposition proceedings — Application for Community word mark SELOGYN — Earlier national word mark SELESYN — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 207/2009 — Refusal to register)

9.2.2015   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 46/47
            
         Judgment of the General Court of 12 December 2014 — Selo Medical v OHIM — biosyn Arzneimittel (SELOGYN)
   (Case T-173/13) (1)
   
   ((Community trade mark - Opposition proceedings - Application for Community word mark SELOGYN - Earlier national word mark SELESYN - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 207/2009 - Refusal to register))
   (2015/C 046/58)
   Language of the case: German
   
      Parties
   
   
      Applicant: Selo Medical GmbH (Unternberg, Austria) (represented by: T. Schneider, lawyer)
   
      Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: D. Walicka, acting as Agent)
   
      Other party to the proceedings before the Board of Appeal of OHIM intervening before the General Court: biosyn Arzneimittel GmbH (Fellbach, Germany) (represented by: R. Kunz-Hallstein and H. Kunz-Hallstein, lawyers)
   
      Re:
   
   Action brought against the decision of the Fourth Board of Appeal of OHIM of 21 January 2013 (Case R 2601/2011-4), relating to opposition proceedings between biosyn Arzneimittel GmbH and Selo Medical GmbH.
   
      Operative part of the judgment
   
   The Court:
   
               1)
            
            
               Dismisses the action;
            
         
               2)
            
            
               Orders Selo Medical GmbH to pay the costs.
            
         
      (1)  OJ C 141, 18.5.2013.